MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction
Briefings in Bioinformatics · 2023
DOI: 10.1093/bib/bbad215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2023. Verfasst von Chen-Di Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China. Hauptthemen laut MEDLINE: Drug Delivery Systems, Neural Networks, Computer. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Adverse drug–drug interactions (DDIs) have become an increasingly serious problem in the medical and health system. Recently, the effective application of deep learning and biomedical knowledge graphs (KGs) have improved the DDI prediction performance of computational models. However, the problems of feature redundancy and KG noise also arise, bringing new challenges for researchers. To overcome these challenges, we proposed a Multi-Channel Feature Fusion model for multi-typed DDI prediction (MCFF-MTDDI). Specifically, we first extracted drug chemical structure features, drug pairs’ extra label features, and KG features of drugs. Then, these different features were effectively fused by a multi-channel feature fusion module. Finally, multi-typed DDIs were predicted through the fully connected neural network. To our knowledge, we are the first to integrate the extra label information into KG-based multi-typed DDI prediction; besides, we innovatively proposed a novel KG feature learning method and a State Encoder to obtain target drug pairs’ KG-based features which contained more abundant and more key drug-related KG information with less noise; furthermore, a Gated Recurrent Unit-based multi-channel feature fusion module was proposed in an innovative way to yield more comprehensive feature information about drug pairs, effectively alleviating the problem of feature redundancy. We experimented with four datasets in the multi-class and the multi-label prediction tasks to comprehensively evaluate the performance of MCFF-MTDDI for predicting interactions of known-known drugs, known-new drugs and new-new drugs. In addition, we further conducted ablation studies and case studies. All the results fully demonstrated the effectiveness of MCFF-MTDDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, 221116, China.
- School of Science, Jiangnan University, Wuxi, 214122, China.
- The Future Laboratory, Tsinghua University, Beijing, 100084, China.
- Artificial Intelligence Research Institute, China University of Mining and Technology, Xuzhou, 221116, China.
ORCID-Profile: Chun-Chun Wang, Xing Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Han, C. D., Wang, C. C., Huang, L., & Chen, X. (2023). MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbad215
Vancouver
Han CD, Wang CC, Huang L, Chen X. MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction. Briefings in Bioinformatics. 2023. doi:10.1093/bib/bbad215
BibTeX
@article{Han2023,
author = {Han, Chen-Di and Wang, Chun-Chun and Huang, Li and Chen, Xing},
title = {MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction},
journal = {Briefings in Bioinformatics},
year = {2023},
doi = {10.1093/bib/bbad215}
}
EUVIMED